ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

140
Analysis
Health Care β€’ Japan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
β€’01 Feb 2021 06:47

πŸ‡―πŸ‡΅ JAPAN β€’ Market + Results & Revisions Update 01/29

Thursday's Vale Traded ratio was the highest year-to-date and the third-highest since the COVID-low of 13th March 2020. Down Volume reached 'Panic'...

Logo
206 Views
Share
bullishβ€’Daiichi Sankyo
β€’01 Nov 2020 08:48

Dai-Ichi Sankyo (4568) Buyback Dynamics

Dai-Ichi Sankyo has announced Q2 earnings, a forecast revision, and a Β₯100bn buyback to pick up where it left off in 2018. This is twice as big as...

Logo
371 Views
Share
bullishβ€’Remegen
β€’23 Oct 2020 10:37

Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC48

This article analyzed two core products from RemeGen: RC18 and RC 48. The commercialization of these two products would have direct impact on the...

Logo
414 Views
Share
x